Recombinant Human SNCA

Description

EnkiLife provides the Recombinant Human SNCA protein,aslo know as Alpha-Synuclein,Non-A Beta Component of AD Amyloid,Non-A4 Component of Amyloid Precursor,NACP,SNCA,NACP,PARK1, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<0.001 EU/µg as determined by LAL test.;Construction:Recombinant Human Alpha-Synuclein is produced by our E.coli expression system and the target gene encoding Met1-Ala140 is expressed.Accession:P37840. Expression Host:E.coli.Species:Human.Predicted Molecular Mass:14.46 KDa. Background:Alpha-Synuclein (SNCA) is a member of the Synuclein family. SNCA is expressed principally in brain but also expressed in low concentrations in all tissues except liver. SNCA interacts with UCHL1, Phospholipase D and histones. SNCA can include beta- and gamma-synuclein. In addition, SNCA is an important regulatory component of vesicular transport in neuronal cells. It has been suggested that SNCA is related to the pathogenesis of Parkinsons Disease and neurodegenerative disorders. Defects in SNCA will lead to Dementia Lewy Body (DLB).